New World Order

CONTD HERE...

Freeman J. Dyson, PhD, Emeritus Professor of Physics, Institute for Advanced Studies, Princeton, N.J.

Don J. Easterbrook, PhD, Emeritus Professor of Geology, Western Washington University

Lance Endersbee, Emeritus Professor, former dean of Engineering and Pro-Vice Chancellor of Monasy University, Australia

Hans Erren, Doctorandus, geophysicist and climate specialist, Sittard, The Netherlands

Robert H. Essenhigh, PhD, E.G. Bailey Professor of Energy Conversion, Dept. of Mechanical Engineering, The Ohio State University

Christopher Essex, PhD, Professor of Applied Mathematics and Associate Director of the Program in Theoretical Physics, University of Western Ontario

David Evans, PhD, mathematician, carbon accountant, computer and electrical engineer and head of 'Science Speak,' Australia

William Evans, PhD, editor, American Midland Naturalist; Dept. of Biological Sciences, University of Notre Dame

Stewart Franks, PhD, Professor, Hydroclimatologist, University of Newcastle, Australia

R. W. Gauldie, PhD, Research Professor, Hawai'i Institute of Geophysics and Planetology, School of Ocean Earth Sciences and Technology, University of Hawai'i at Manoa

Lee C. Gerhard, PhD, Senior Scientist Emeritus, University of Kansas; former director and state geologist, Kansas Geological Survey

Gerhard Gerlich, Professor for Mathematical and Theoretical Physics, Institut für Mathematische Physik der TU Braunschweig, Germany

Albrecht Glatzle, PhD, sc.agr., Agro-Biologist and Gerente ejecutivo, INTTAS, Paraguay

Fred Goldberg, PhD, Adjunct Professor, Royal Institute of Technology, Mechanical Engineering, Stockholm, Sweden

Vincent Gray, PhD, expert reviewer for the IPCC and author of The Greenhouse Delusion: A Critique of 'Climate Change 2001, Wellington, New Zealand

William M. Gray, Professor Emeritus, Dept. of Atmospheric Science, Colorado State University and Head of the Tropical Meteorology Project

Howard Hayden, PhD, Emeritus Professor of Physics, University of Connecticut

Louis Hissink MSc, M.A.I.G., editor, AIG News, and consulting geologist, Perth, Western Australia

Craig D. Idso, PhD, Chairman, Center for the Study of Carbon Dioxide and Global Change, Arizona

Sherwood B. Idso, PhD, President, Center for the Study of Carbon Dioxide and Global Change, AZ, USA

Andrei Illarionov, PhD, Senior Fellow, Center for Global Liberty and Prosperity; founder and director of the Institute of Economic Analysis

Zbigniew Jaworowski, PhD, physicist, Chairman - Scientific Council of Central Laboratory for Radiological Protection, Warsaw, Poland

Jon Jenkins, PhD, MD, computer modelling - virology, NSW, Australia

Wibjorn Karlen, PhD, Emeritus Professor, Dept. of Physical Geography and Quaternary Geology, Stockholm University, Sweden

Olavi Kärner, Ph.D., Research Associate, Dept. of Atmospheric Physics, Institute of Astrophysics and Atmospheric Physics, Toravere, Estonia

Joel M. Kauffman, PhD, Emeritus Professor of Chemistry, University of the Sciences in Philadelphia


David E. Wojick, PhD, P.Eng., energy consultant, Virginia

Raphael Wust, PhD, Lecturer, Marine Geology/Sedimentology, James Cook University, Australia

A. Zichichi, PhD, President of the World Federation of Scientists, Geneva, Switzerland; Emeritus Professor of Advanced Physics, University of Bologna, Italy?????

David Kear, PhD, FRSNZ, CMG, geologist, former Director-General of NZ Dept. of Scientific & Industrial Research, New Zealand

Madhav Khandekar, PhD, former research scientist, Environment Canada; editor, Climate Research (2003-05); editorial board member, Natural Hazards; IPCC expert reviewer 2007

William Kininmonth M.Sc., M.Admin., former head of Australia's National Climate Centre and a consultant to the World Meteorological organization's Commission for Climatology Jan J.H. Kop, MSc Ceng FICE (Civil Engineer Fellow of the Institution of Civil Engineers), Emeritus Prof. of Public Health Engineering, Technical University Delft, The Netherlands

Prof. R.W.J. Kouffeld, Emeritus Professor, Energy Conversion, Delft University of Technology, The Netherlands

Salomon Kroonenberg, PhD, Professor, Dept. of Geotechnology, Delft University of Technology, The Netherlands

Hans H.J. Labohm, PhD, economist, former advisor to the executive board, Clingendael Institute (The Netherlands Institute of International Relations), The Netherlands

The Rt. Hon. Lord Lawson of Blaby, economist; Chairman of the Central Europe Trust; former Chancellor of the Exchequer, U.K.

Douglas Leahey, PhD, meteorologist and air-quality consultant, Calgary

David R. Legates, PhD, Director, Center for Climatic Research, University of Delaware

Marcel Leroux, PhD, Professor Emeritus of Climatology, University of Lyon, France; former director of Laboratory of Climatology, Risks and Environment, CNRS

Bryan Leyland, International Climate Science Coalition, consultant and power engineer, Auckland, New Zealand

William Lindqvist, PhD, independent consulting geologist, Calif.

Richard S. Lindzen, PhD, Alfred P. Sloan Professor of Meteorology, Dept. of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology

A.J. Tom van Loon, PhD, Professor of Geology (Quaternary Geology), Adam Mickiewicz University, Poznan, Poland; former President of the European Association of Science Editors

Anthony R. Lupo, PhD, Associate Professor of Atmospheric Science, Dept. of Soil, Environmental, and Atmospheric Science, University of Missouri-Columbia

Richard Mackey, PhD, Statistician, Australia

Horst Malberg, PhD, Professor for Meteorology and Climatology, Institut für Meteorologie, Berlin, Germany

John Maunder, PhD, Climatologist, former President of the Commission for Climatology of the World Meteorological Organization (89-97), New Zealand

Alister McFarquhar, PhD, international economy, Downing College, Cambridge, U.K.

Ross McKitrick, PhD, Associate Professor, Dept. of Economics, University of Guelph

John McLean, PhD, climate data analyst, computer scientist, Australia

Owen McShane, PhD, economist, head of the International Climate Science Coalition; Director, Centre for Resource Management Studies, New Zealand

Fred Michel, PhD, Director, Institute of Environmental Sciences and Associate Professor of Earth Sciences, Carleton University

Frank Milne, PhD, Professor, Dept. of Economics, Queen's University

Asmunn Moene, PhD, former head of the Forecasting Centre, Meteorological Institute, Norway

Alan Moran, PhD, Energy Economist, Director of the IPA's Deregulation Unit, Australia

Nils-Axel Morner, PhD, Emeritus Professor of Paleogeophysics & Geodynamics, Stockholm University, Sweden

Lubos Motl, PhD, Physicist, former Harvard string theorist, Charles University, Prague, Czech Republic

John Nicol, PhD, Professor Emeritus of Physics, James Cook University, Australia

David Nowell, M.Sc., Fellow of the Royal Meteorological Society, former chairman of the NATO Meteorological Group, Ottawa

James J. O'Brien, PhD, Professor Emeritus, Meteorology and Oceanography, Florida State University

"this thread deals with serious issues."

The last thing I would ever deny is the seriousness of your issues.

Cliff Ollier, PhD, Professor Emeritus (Geology), Research Fellow, University of Western Australia

Garth W. Paltridge, PhD, atmospheric physicist, Emeritus Professor and former Director of the Institute of Antarctic and Southern Ocean Studies, University of Tasmania, Australia

R. Timothy Patterson, PhD, Professor, Dept. of Earth Sciences (paleoclimatology), Carleton University

Al Pekarek, PhD, Associate Professor of Geology, Earth and Atmospheric Sciences Dept., St. Cloud State University, Minnesota

Ian Plimer, PhD, Professor of Geology, School of Earth and Environmental Sciences, University of Adelaide and Emeritus Professor of Earth Sciences, University of Melbourne, Australia

Brian Pratt, PhD, Professor of Geology, Sedimentology, University of Saskatchewan

Harry N.A. Priem, PhD, Emeritus Professor of Planetary Geology and Isotope Geophysics, Utrecht University; former director of the Netherlands Institute for Isotope Geosciences

Alex Robson, PhD, Economics, Australian National University Colonel F.P.M. Rombouts, Branch Chief - Safety, Quality and Environment, Royal Netherland Air Force

R.G. Roper, PhD, Professor Emeritus of Atmospheric Sciences, School of Earth and Atmospheric Sciences, Georgia Institute of Technology

Arthur Rorsch, PhD, Emeritus Professor, Molecular Genetics, Leiden University, The Netherlands

Rob Scagel, M.Sc., forest microclimate specialist, principal consultant, Pacific Phytometric Consultants, B.C.

Tom V. Segalstad, PhD, (Geology/Geochemistry), Head of the Geological Museum and Associate Professor of Resource and Environmental Geology, University of Oslo, Norway

Gary D. Sharp, PhD, Center for Climate/Ocean Resources Study, Salinas, CA

S. Fred Singer, PhD, Professor Emeritus of Environmental Sciences, University of Virginia and former director Weather Satellite Service

L. Graham Smith, PhD, Associate Professor, Dept. of Geography, University of Western Ontario

Roy W. Spencer, PhD, climatologist, Principal Research Scientist, Earth System Science Center, The University of Alabama, Huntsville

Peter Stilbs, TeknD, Professor of Physical Chemistry, Research Leader, School of Chemical Science and Engineering, KTH (Royal Institute of Technology), Stockholm, Sweden

Hendrik Tennekes, PhD, former director of research, Royal Netherlands Meteorological Institute

Dick Thoenes, PhD, Emeritus Professor of Chemical Engineering, Eindhoven University of Technology, The Netherlands

Brian G Valentine, PhD, PE (Chem.), Technology Manager - Industrial Energy Efficiency, Adjunct Associate Professor of Engineering Science, University of Maryland at College Park; Dept of Energy, Washington, DC

Gerrit J. van der Lingen, PhD, geologist and paleoclimatologist, climate change consultant, Geoscience Research and Investigations, New Zealand

Len Walker, PhD, Power Engineering, Australia

Edward J. Wegman, PhD, Department of Computational and Data Sciences, George Mason University, Virginia

Stephan Wilksch, PhD, Professor for Innovation and Technology Management, Production Management and Logistics, University of Technolgy and Economics Berlin, Germany

Boris Winterhalter, PhD, senior marine researcher (retired), Geological Survey of Finland, former professor in marine geology, University of Helsinki, Finland

*Buckaroo* wrote:

furriner wrote:In keeping with the 'mood' in this thread:

Mein Bhabhi se bola,
Kya bhaisaabkidutype mein aajaon?
Bhadak gayee saali
Rehman bola, goli chalaoonga
Mein bola, ekrandikevaaste?
Chalaav goli, gaandu.


Arun Kolatkar.

this thread deals with serious issues. Please do not trivialize.

tia

To quote Kolatkar, Bucks:

Chalaav goli, gaandu.


BTW, Kolatkar is not trivial.

That's a step up from your usual posts.

Yet another expose of the 'International Conspiracy Of Everybody In The World Who Doesn't Agree With Us.'

Fred Nerk wrote:zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz

Dello, can you put this dickhead back in his box?

The Pharmaceutical Racket

http://www.truthcampaign.co.uk/

The Pharmaceutical RacketIn the early half of this century the petrochemical giants organised a coup on the medical research establishments, hospitals and universities. The Rockefellers did this by sponsoring research and donating monetary gifts to US universities and medical schools where research was drug based and
further extended this policy to foreign medical establishments via their International Education Board. Those who were not drug based were refused funding and were soon dissolved in favour of the more lucrative pharmaceutical-based projects.
In 1939 the 'Drug Trust' alliance was formed by the Rockefeller Empire and I.G. Farben. After the war, I.G. Farben was dismantled but later emerged in the many guises of the companies with whom they had signed cartel agreements. These companies include: Imperial Chemical Industries (ICI), Borden, Carnation, General Mills, M.W. Kellogg Co., Nestle, Pet Milk, Squibb and Sons, Bristol Meyers, Whitehall laboratories, Procter and Gamble, Roche, Hoechst and Beyer and Co. (two extant pharmaceutical companies who initially employed convicted war criminals Friedrich Jaehne and Fritz ter Meer as board chairmen). The Rockefeller Empire – in tandem with the Chase Manhattan Bank now owns over half of the USA's pharmaceutical interests and is the largest drug manufacturing combine in the world. Since the war the drug industry has steadily netted an ever increasing profit from sales of drugs to become the second largest manufacturing industry in the world next to the arms industry (also owned by the self same Elite agencies).

Today, health care is a multi-billion pound industry world-wide with ever increasing expenditure by taxpayers into the system which funnels the majority of this staggering profit into the hands of the drug manufacturers who are, as we have seen, headed by the major Elite manipulators of this century. These companies now control the vast majority of health care and set the standards for the practice of medicine in all developed countries. Doctors are no longer free to choose the most reliable and safe forms of therapy available but are at the mercy of their financial reliance on sponsoring (frequently bribing) drug companies. Once out of drug-company sponsored medical school, doctors embark on a career of increasing workloads and have ever increasing amounts of new pharmaceutical products to use and understand. The sheer volume of literature which a GP will receive from drug sales reps has resulted in
the present situation whereby GPs are poorly educated about the chemicals which they are giving to their patients and are essentially gleaning most of their post-graduate training from the salesmen of private business. The moral implications of this are staggering.

The number of available drug preparations is now well in excess of 200,000. In 1980, the World Health organisation advised that a mere 240 drugs are necessary in order to provide good health care in the Third World (which should be more than adequate for First World needs considering we are a significantly healthier proportion of the population) whilst in 1981 the United Nations Industrial Development Organisation stated that a mere 26 of these are considered 'indispensables'. Most of the many drugs which are now available are known as 'me-too' drugs, i.e. recombinations and exact reproductions of drugs already available but which are irresistible to other companies who wish to share in their market. For example, the standard analgesics Paracetamol and Aspirin come in a multitude of forms under a variety of different brand names and yet these products can vary in price to a factor of ten or more times for the exact same formula depending on brand type chosen. Often the consumer erroneously presumes that increased price is equivalent to increased quality in this case and are entirely unaware that the drugs they are buying and those which they are rejecting are identical. Doctors are also often guilty of prescribing drugs by trade name and thus netting greater profits for the favoured company whilst cheaper versions are available to the unwary consumer/patient. Usually, before handing in a prescription it pays to consult the attending pharmacist if there is an equivalent and cheaper drug
available. This can save some chronic drug users hundreds of pounds per year.

Pharmaceutical companies rely upon ill health in the population to survive and reap their profits. No drug company has a vested interest in curing disease. They do, however, have a massive vested interest in maintaining ill-health, creating disease and manufacturing chemicals which will promote this under the guise of 'therapy' for the symptoms – rarely ever the cause – of disease. Dr John Braithwaite, now a Trade Practices Commissioner, in his expose, Corporate Crime in the Pharmaceutical Industry, states:

'International bribery and corruption, fraud in the testing of drugs, criminal negligence in the unsafe manufacturing of drugs – the pharmaceutical industry has a worse record of law-breaking than any other industry.'

In the US in 1978 1.5 million people were hospitalised because of medication side-effects alone. In 1991 in the US, 72,000 people were killed due to iatrogenic – that is doctor-induced – causes whilst 24,073 died of victims of firearms shootings, which makes doctors nearly three times more lethal than guns! This has serious implications for other countries including Britain because the US are the foremost pioneers in the health care field and what occurs in health care in the US is usually implemented in Britain a decade later.

The drugs industry has managed to sell to the majority of the world the idea that disease is largely an inevitable part of life, especially during the later years. Through its front-line representatives – the medical system – it has effectively reduced the range of choices of health care to which the public has access. Through funding and educational control it has seen to it that natural forms of treatment are largely ignored and grossly under-researched. Those organisations which do reveal the true causes of disease and promote effective forms of disease prevention, such as nutritional medicine, healing and naturopathy are regularly attacked in the mass media and publicly labelled as quacks by pharmaceutically-sponsored de-bunking organisations such as the Campaign Against Health Fraud, now called Healthwatch.

They have also sold to us the idea that natural remedies and cures which have been successfully employed for centuries are 'alternatives' and to be treated with great scepticism and caution. Frequently, we are told of how one or two people have been injured or killed through the misapplication of a herbal remedy by dubious alternative practitioners but are not told at the same time of the thousands who are damaged by the conventional drugs which are handed out like sweets by our doctors.

During their initiation into the Western medical tradition most of our young doctors are repeatedly informed by their superiors that therapies which are alternative to classic western medicine are fraudulent and quackish. They are told that there is no scientific evidence to support any of the claims of psychic healing, crystal therapy, colour therapy and the like and the whole area is dismissed with a superior grin and a wave of the hand. A mountain of study is then hurled at the junior doctors, on top of an already inhumane workload of practical hours, to be spent absorbing the biased views of their forebears. A junior doctor has not even enough time to explore the realms of stress-free relaxation never mind alternative thought and therapies. Much the same methods are used by certain religious organisations to indoctrinate the minds of their followers into a single belief system. The key tactics, to which most doctors will relate, are: maintenance of sleep deprivation so as to minimise resistance to teachings, isolation from the outside world until one is literally eating, breathing and sleeping the set doctrine of the cult, and maintenance of a fear of failure to conform through almost unachievably high level goal setting; often via frequent examinations.

I believe that western medicine is as much a dogmatic cult as popular Christianity or the Moonies. It breeds its young on dogma to the exclusion of free will and reasoned thought in order to perpetuate itself. It is controlled by instilling into its members the fear of failure and it thrives by exploiting the initial motivation of its members, which is love and a desire to help and heal others.

At the apex of the pyramid of medicine lie the controllers; not doctors, but the multinational pharmaceutical companies who exist, not for the benefit of others, but for the desire for money and power. And behind them lies the sinister organisation of global secret societies headed by the Illuminati.

It is through this subtle mind control that the System maintains itself. Veiled in secrecy and fuelled by fear, the monster machine controls every aspect of our lives. The medical system is an integral part, but nevertheless only one aspect, of the overall design which seeks power and neither cares how this power is achieved, nor how many individuals are destroyed in the process.

As an example of the fraud perpetuated by the pharmaceutical companies, the next section will take a close look at the AIDS scandal, which illuminates how these companies have infiltrated every area of the healthcare system are willing to endanger people, allowing them to be killed, for profit via the industry's tool of corruption and front organisation, our own medical system:

What is AIDS?

AIDS is defined as any one of twenty five unrelated diseases plus a positive test for the presence of antibodies to the Human Immuno-deficiency Virus (HIV). It is said to be transferred through intimate sexual contact via the transfer of bodily fluids such as semen and blood. It is also said to be passed on through intravenous means by needle-sharing drug users and infected blood transfusions.

Nearly five hundred scientists world-wide, including eminent doctors such as leading University of California Professor of Molecular Biology, Peter Duesberg, and Australian biophysicist Eleni Papadopoulous-Eleopoulos, Dr Charles Thomas (former Harvard Professor of Biochemistry), Dr Kary Mullis (1993 Nobel Prize-winner for Chemistry), Dr Hank Loman (Professor of Biophysical Chemistry, Free University of Amsterdam), and Dr Steven Lomas (Professor of Preventative Medicine, State University of New York) are now convinced that AIDS is not caused by HIV.

In simple terms, the facts just do not add up. For example, there are many people with AIDS but without HIV and vast numbers of people who are HIV positive are not developing AIDS. The tests for the presence of retrovirus HIV – the Western Blot Test and the ELISA Test – which show up HIV positive status, are so inaccurate that false positive tests can occur due to many diseases such as malnutrition, multiple infections, multiple sclerosis, tuberculosis, leprosy, having once had the 'flu' or measles and the bodies natural response to anal semen.

Once diagnosed as HIV positive, patients are given regular blood tests to monitor their immunological responses, particularly for a drop in T-cell count. T-cells are released in the immune response to disease to attack invading antigens. A significant T-cell drop, in many clinics, is the indicator that active drug therapy should be commenced. However, using T-cell counts as an indicator of disease is entirely useless as the average T-cell count for a healthy person can range from 200 to 2000 over the course of a normal day. Professor Ian Weller, who co-ordinated the British arm of the Concorde AZT trial testing the drug on healthy HIV-positive volunteers, commented:

'The thing we have to remember about CD4 (T-cell) counts is they are very variable. They can vary in an individual over the time of day... lower in the morning and higher in the evening. They can be affected by things that you do such as walking to the clinic, as opposed to riding a bike... the amount of sunshine can affect them. Smoking as well.'

This whole area of inaccurate testing in the area of AIDS and AIDS Related Conditions (ARC) has accounted for many people being incorrectly diagnosed as HIV positive, such as in Africa where there is a supposed epidemic; there is also a massive amount of otherwise unrelated disease there too and it is this factor which is causing the false positives.

Once diagnosed, patients are then initiated onto courses of highly toxic drugs such as AZT, DDI and Septrin, many of the side effects of which are the self same symptoms as those of AIDS.

None of these AIDS defining diseases are new. What is new, however, is the HIV test. All research into this syndrome has been based upon the findings of Robert Gallo, the co-founder and patent holder of the test, which have since been found to be fraudulent. Gallo's partner and co-founder of the HIV theory, Luc Montagnier, declared in 1989:

'HIV is not capable of causing the destruction to the immune system which is seen in people with AIDS'.

One medical doctor who has practised and lectured on medicine world-wide for over thirty five years, Dr. Robert E. Wilner has even publicly demonstrated that HIV does not cause disease by injecting himself with the blood of an HIV positive patient on Spain's most popular television show; yet this never made it to the press outside of Spain! In his book 'Deadly Deception: The Proof That Sex And HIV Absolutely Do Not Cause AIDS', Dr. Wilner cites AZT as one of the major causes of AIDS, he also insists that 'HIV is simply a harmless piece of tissue, not unlike numerous other retroviruses that exist in our body' and that 'AIDS is not transmitted sexually nor is it contagious by any method!'

Dr Duesberg, recognised as one of, if not the foremost retrovirus expert in the world, points out:

'AZT is A Random Killer Of Infected And Non-Infected Cells. AZT cannot discriminate among them. It kills T-cells, B-cells, red cells, it kills all cells. AZT is a chain terminator of DNA synthesis of all cells – no exceptions. It wipes out everything. In the long run it can only lead to death of the organism – and the cemetery. AZT is a certain killer! Who will be responsible for the death of patients (some 200,000 now being treated with AZT and countless thousands who have already died from it in the past decade) that results from AZT therapy – pharmacological homicide?'

And furthermore, that:

'HIV does not cause AIDS... The point that everyone is missing is that all of those original papers, Gallo wrote on HIV have been found fraudulent... The HIV hypothesis was based on those papers.'

It is my opinion that these scientists are correct and that HIV is not the cause of AIDS. AIDS is not a single viral disease but a collection of, in part, unrelated diseases which are caused by disharmonious energies in the fields of the holistic body, brought about by all sorts of reasons. Undoubtedly one of the major causes of death by AIDS-related diseases is the inability of the body to fight off the manifested disease because the body has been weakened by the very drugs given to suppress the disease. Tests have shown that the only effective treatments for AIDS are those which involve the cessation of conventional drugs in favour of unconventional natural therapies such as Essiac, Oxygen/Ozone Therapy and CanCell. However, these natural therapies share a common theme in that they have all been suppressed or withdrawn by governmental agencies and those with vested interests in the
pharmaceutical industry.

(To further support the fact that HIV is not transferred sexually, Cathy O'Brien in her book Trance Formation Of America, points out that, despite being prostituted to men in areas supposedly rife with AIDS, none of her political abusers ever wore protection during sex with her.)

Wellcome to Hell (compiled from Dirty Medicine by Martin J Walker – see reference below)

Wellcome (Wellcome Burroughs in the US) began as a pharmaceutical company set up in 1880 by Henry Wellcome and Silas Burroughs. Its links to the Rockefeller Empire were apparent in Henry Wellcome's appointing of John and Allen Dulles of the Sullivan and Cromwell law firm as those responsible for any legal matters relating to the company and his own will. With Henry Wellcome's death in 1936, the Wellcome Trust was set up in conjunction with the company (now the Wellcome Foundation) and this has now become one of the largest funders of medical research in Europe. The Rockefeller connection was also strengthened in the late 50's when Wellcome took over the running of aspects of the Rockefeller funded London University College Hospital Medical School and their joint interests in tropical illness research via the London School of Hygiene and Tropical Medicine.

Over the following decades, Wellcome pursued several aspects of pharmaceutical healthcare with interests in general over-the-counter remedies, anti-virals, animal healthcare, genetic engineering and biotechnology. It strengthened its connections within the government, the media, medical academia and the various committees, societies and associations that were continuously being set up to review, regulate and control all aspects of scientific medical research and education. It did this by making donations to many of these organisations, such as the British Association for the Advancement of Science, the Parliamentary Science and Technology Foundation, the Parliamentary Office of Science and Technology, and the British Medical Association's Foundation for AIDS (to which it gave £144,000 between 1988 and 1992), and by placing its own trustees, researchers and 'experts' in prominent positions within them. For example: Sir Alastair Pilkington one time vice president of the Foundation for Science and Technology was a research scientist for Wellcome; Professor C. Gordon Smith, Dean of the London School of Hygiene and Tropical Medicine was a Wellcome trustee; Lord Swann, Director of the BBC in the 1980's was a Wellcome trustee; Sir Alfred Shepperd, a member of the Advisory Council on Science and Technology(ACST) was Chairman of Burroughs Wellcome and the Wellcome Foundation until 1985; Professor Roy Anderson, Head of Pure and Applied Biology at London Imperial College of Science, Technology and medicine and a member of ACST was also a Wellcome trustee.

In the 1980's however, the company went through some major rationalisations. In 1986 the decision was made to sell shares in the Welcome drug company which had previously been owned in its entirety by the Wellcome Trust. In the following six years it also sold off several areas of business including Cooper Animal Healthcare – a joint venture with ICI producing organo-phosphate sheep dip – and its interests in vaccine production. Production of general cough and cold remedies was also reduced to a mere 14% of sales while it began concentrating its funds in the more profitable areas of genetics, biotechnology and anti-virals.

AZT, marketed by Wellcome as Retrovir, had been developed in the 60s as a drug to treat cancer but it had proved to be highly toxic as well as ineffective as it appeared unable to distinguish between cancerous and healthy cells. However, tests in vitro appeared to show some anti-viral properties which was why, after being shelved in the 60s, AZT was re-tested for use in the treatment of AIDS in the 1980s.

Human clinical drug trials, following extensive (though useless) animal testing, usually take place in two parts. Phase I tests for toxicity; Phase II concentrates on the long-term side-effects and efficacy, all of which can take several years. In the case of AZT the Phase II trials in America were halted after 4 months when only 1 of the AZT users as opposed to 19 of the control group had died and the drug was granted a license despite the fact that the patients in the trial were given regular blood transfusions to alleviate the possible side-effects (this should, under usual circumstances, have negated the results of the trial). This licensing of AZT so quickly was unprecedented and made Wellcome's profits double to £1132 million in the space of 4 years! As if this wasn't enough, subsequent licenses for other AIDS drugs were issued subject to the condition that they would have to be tested against AZT and then only prescribed in conjunction with it.

Incredibly, AZT was licensed in the UK without any clinical trials four weeks before it was licensed in the US. This, perhaps, may have been due to the fact that, of the 25 members of the Medicines Commission who are parliamentary advisers on medicine, 5 had interests in Wellcome; one prominent member being Professor Trevor M. Jones, Director of Research and Development at Wellcome. And of the 21 members of the Committee on the Safety of Medicines who grant the licenses, two had interests in the Welcome Foundation.

Within a short space of time, AZT was licensed in 35 countries around the world and Wellcome were promoting it with media advertising, press releases and all-expenses-paid conferences to which they regularly invited the world's top scientists and physicians, all the while denying any suggestions that it caused harmful side-effects.

Wellcome's influence on the media and the government continued with its donation of £10,000 to the All Party Parliamentary Group on AIDS (APOGA) as, with the Medical Research Council, Wellcome began the trials of AZT on asymptomatic HIV positive patients – the Concorde trials – in October 1988. From that point onwards most of the doctors presenting information and writing for APGOA were also involved in these trials. Not content with promoting their own research in the area of AIDS they also began to attack any alternative treatments or anyone who challenged the HIV=AIDS hypothesis.

Wellcome had also cornered the British market in AIDS testing kits. With the help of Dr. Robin Weiss and Angus Dalgleish from the Institute of Cancer Research, a second generation kit was marketed based on the research by Campaign Against Health Fraud (now Healthwatch) member, Professor Vincent Marks, head of the Biochemistry Department of Surrey University – a department which has received over half a million pounds from Wellcome since 1985. In order to ensure that anyone found to be HIV positive was immediately directed towards 'help' from AZT-promoting doctors, GP's were given very limited access to the testing kits. They had no choice but to send their patients to Wellcome-infiltrated teaching hospitals and STD clinics in London while the promotion and sale of home testing kits was banned in the UK (in 1992), thereby ensuring Wellcome's complete monopoly in all aspects of AIDS treatment and diagnosis.

Education about HIV and AIDS could also not be overlooked and Wellcome donated substantial funds to pay for a £150,000 package for GPs, produced by the British Medical Association.

The Concorde trials themselves, instead of being independent, were almost totally under Wellcome's influence. The initial reason for the trials was to prove that AZT would be effective in preventing the development of ARC and AIDS in otherwise healthy HIV+ patients. Going against all established regulations for the independence of such trials, which in the past had the drug companies supplying the drug and paying the hospitals to do the trials, the Concorde trial was set up jointly between Wellcome, the Medical Research Council (MRC) and the Department of Health. The MRC paid for the treatment and the Department of Health granted the use of six London hospitals, NHS staff and facilities. Anyone with an HIV positive test was encouraged to join the trial without discussion of any alternative treatments whilst being promised up to 3 years of free healthcare despite the fact that the AZT drug was to be administered at 1000mg per day – twice the dose recommended by the US Food and Drug Administration – and the recent reports of serious side-effects such as muscle wasting, anaemia and impotence. Wellcome's crowning glory in this deal, though, was to also insist that the contract gave them complete control over the writing of any reports about the trial. The only report which had to be agreed between all parties was the one for general publication, if indeed any published report was even deemed necessary.

Just to make absolutely sure of obtaining the desired outcome, Wellcome had the help of several 'friends' in the MRC who had just as many, if not more, commitments to industry and business matters than they did to the medical establishment or the government. Lord Jellicoe, Chairman of the MRC's AIDS committee, was a director of the Rockefeller company Morgan Crucible as well as the sugar company Tate and Lyle and was later chairman of Booker Tate confectionery; Sir Donald Acheson worked for the Department of Health but left in 1991 to work in the Rockefeller funded School of Hygiene and Tropical Medicine; Sir Austin Bide was Chief Executive of Glaxo (now in partnership with Wellcome) and had been a director of J. Lyons & Co confectionery in the 70's. Sir David Crouch, MP for Canterbury until 1987, was director of Pfizer Ltd., a pharmaceutical company which was the only manufacturer of a synthesised ingredient of AZT at that time and also ran several public relations companies one of which, Kingsway Rowland, handled Wellcome's AZT account; Dr J. W. G. Smith, director of the Public Health Laboratory Service since 1985 used to be a Senior Lecturer at the School of Hygiene and Tropical Medicine before going to work for Wellcome as head of Bacteriology in 1969; Professor D. A. Warrell was a director of the Wellcome Tropical Research Unit and has also done malaria research funded by Wellcome and the Rockefeller Foundation; Professor C. N. Hales is a specialist in diabetes whose research is often funded by pharmaceutical companies including Wellcome.

With the above as the only 8 members of the MRC Committee on AIDS and their Chairman Lord Jellicoe, it is not surprising that a drug once deemed to be too toxic, which has never been properly tested and whose side-effects, according to the British National Formulary, bear s striking resemblance to the symptoms of AIDS itself, has been allowed to become the AIDS drug of the 90's and has kept the profits rolling in for Wellcome to the tune of an estimated £400 million a year.

Walker, Martin J.; Dirty Medicine: Science, big business and the assault on natural health care, (Slingshot Publications, London, 1994).

AIDS Care and Treatment

'I will give no deadly medicine to any one if asked.'
(from the Hippocratic Oath)

Walter's position as a staff nurse at Newcastle General Hospital's Infectious Disease Unit (ward 25), which is affiliated with the London School of Tropical Medicine, has given me an insight into the world of AIDS treatment which is rarely seen and it only serves to corroborate the research of the aforementioned enlightened scientists, whose numbers are ever increasing. The world of AIDS care and treatment at the NGH has some very sinister elements and I have no reason to suspect that it is isolated to this regional unit alone. Here is an outline of some of the information which Walter has provided:

According to the code of conduct provided by the United Kingdom Central Council for nursing and midwifery, the nurse's role is to be the patient's advocate and is, therefore, entrusted to provide care in the best interest of the patient and to decline from doing anything which is detrimental to their well being. One of the major areas covered by this is in the administration of drugs; the nurse is responsible for ensuring the correct dosage of drug is given and is responsible also for being aware of the effects and possible side effects of the medication.

However, in the NGH unit, nurses are expected to give all drugs prescribed by the doctor whether or not any information on the effects of the drug are available. Frequently the prescribing doctor is unaware of the true nature of the drugs and thus unable to inform the nursing staff of the effects and side effects of the drugs they are using. Many and varied substances appear and disappear periodically from the drugs cupboard, often named only as a series of numbers or letters. When challenged as to the reason why they have prescribed such unknown entities, the doctors usually reply that their consultant has ordered it to be given. The consultant is usually unavailable for comment.

The side effects of the drugs have been seen to be potentially harmful. For example, one commonly used drug, Foscarnet, which is given directly into the heart or eyes of a patient, when dropped on a nurse's tights dissolved them on contact. Common side effects of this drug include epilepsy, blindness and dementia. Many patients have entered the unit with minor symptoms such as weight loss and have, in a short space of time, become blind and epileptic through using it. Walter has frequently said to me, 'I'm poisoning people for a living', but if he refused to give the drugs as prescribed he would lose his job and someone would be found who would administer them. The same is true of the junior doctors who are afraid of the vengeance from above if they were to challenge the status quo. No challenge has yet been made, even after I presented the unit with detailed papers outlining the research which has negated the 'HIV equals AIDS' myth.

Once diagnosed as HIV positive, many patients are then informed that the only chance they have for extended survival is to use the drugs provided. Obviously the majority of patients, many of whom show very few symptoms, are too afraid not to co-operate with the regime. They then suffer terribly and die a lingering and undignified death.

As a response to many challenges Walter has made to the medical staff to justify their drugs regime, he has been branded cynical and defeatist; as not wishing to give the patients a chance for survival. In reply to this he has asked on many occasions for the doctors to give him even just one example of anyone whom they have cured of AIDS or significantly improved the quality of life. Not one of them has been able to give such an example.

Even if we were extending people lives, in doing so we also inflict upon them such diseases as makes for little or no quality of life. What is the point of an extra year of life if that year is spent as a living vegetable? If we do have a prognosis of death, then surely it is better to live that remaining life to the full with our eventual demise being as gentle and as dignified as possible.


On one occasion, the unit exceeded its drugs budget and feared a crisis in care. At this point Wellcome stepped in and offered its services for free on the condition that they would supply the drugs as long as all research notes were given directly to them in return. It appears that the only figures who were aware of anything like the full picture were the consultants in charge and the research nurse appointed by the company, none of whom were willing to reveal anything of the results of these apparently blind drugs trials.

In effect, this means that the patients on this unit are being treated by the pharmaceutical scientists as human guinea pigs, in order to test the various drugs supplied. How are we to know that these drugs are genuinely safe for the purpose of therapy? Might they simply be poisons or ineffectual chemicals thrown onto the research pot in a vain attempt to happen across some element of cure? Are they even actively seeking a cure, knowing what we do of their motivation?

Some of the drugs which have been identified and are in regular use have long since been discontinued in other areas of medicine because they are ineffective and/or dangerous. For example, A.Z.T. was once considered too toxic to be given to terminally ill cancer patients!

Interestingly, the official patient leaflet, 'HIV and AZT, the choices', as supplied to AIDS departments by Wellcome, gives merely three examples of side effects of the drug, i.e. anaemia, which they say effects up to 40% of users; headaches in 1-10% of users; and sickness in 25% of users which: 'almost always disappear after a few weeks of treatment'. The leaflet also states:

Most people do not suffer side effects when they take AZT early. If they do occur, there are ways of coping with them. They may be reversed, if necessary by stopping treatment.

If you thought that you may be facing death through an incurable disease would you stop taking the drug that has been hyped as giving an extension of lifespan, I wonder?

Septrin is a combination of two antibiotics and has been shown to be far less effective and far more liable to dramatic side effects than either of the components when used individually (interestingly, it is also nearly three times more expensive than the more effective and less harmful constituent ingredient Trimethorprim).

Even Thalidomide is now being used on Ward 25 for its anti-emetic properties.


Many patients diagnosed as terminally ill have drawn up living wills in which they often request a cessation of active treatment in the end stages of disease. These are frequently ignored by the doctors who continue to pump toxins into dying patients and claim to be simply following orders from above. The point of which escapes myself and Walter and quite often the doctors themselves.


When a patient dies, relatives are officially informed that their loved ones are deemed as dangerous waste and must, therefore, be sealed and cremated for hygiene reasons. No mention is made of autopsy or further experimentation and yet Walter has witnessed conversations amongst doctors regarding autopsy findings on such people who were supposed to have gone to cremation unmolested. Is this further pharmaceutical research?


One evening, in the absence of an available doctor from the unit, Walter had to call upon a consultant from another area to advise upon a matter. Whilst this covering doctor was attending to the issue Walter made known his concerns about the dangerous amounts of drugs a patient was prescribed. This consultant agreed with Walter that it was excessive and dangerous and complied with his request to discontinue the majority of the drugs. He also admitted to Walter that there was definitely something extraordinary and far reaching going on in this area which was beyond
his jurisdiction. Furthermore, if he had his way, the majority of the drugs given on the unit would never have been prescribed in the first place. However, 'see no evil, hear no evil, speak no evil' seemed to be the order of the day and that was the end of the matter.

All of this information is deeply disturbing. As more and more evidence mounts against the HIV theory, it seems that the only way to survive AIDS is to steer clear of the medical profession and its terrible
drugs. If it is true of this one syndrome then how true is it of other areas of disease? Just how manipulated are we by these companies? And how much wheeling and dealing is going on behind the scenes between consultants and pharmaceutical companies which directly effects our well-being?

AIDS is a huge money spinner providing millions of pounds of profit per day in drugs sales and its offshoot market of condom sales (Wellcome also has links with the London Rubber Company). It has instilled a fear in the heart of our society of free sexual expression and has given rise to much bigotry from the poorly educated who see AIDS as a judgement from God or a punishment for active homosexuality. It has created a huge charity industry, netting millions of pounds from the world
population to fund further research to rid the world of this affliction. And how much misery and negativity has it generated? Further research means more experiments on both animals and humans. And the
figures for economic growth just rise and rise.

Rothschilds & Rockefellers - Trillionaires Of The World

A recent article in the London Financial Times indicates why it is impossible to gain an accurate estimate of the wealth of the trillionaire bankers. Discussing the sale of Evelyn Rothschild's stake in Rothschild Continuation Holdings, it states: ...[this] requires agreement on the valuation of privately held assets whose value has never been tested in a public market. Most of these assets are held in a complex network of tax-efficient structures around the World.

By this method, the trillionaire masters of the universe remain hidden whilst Forbes magazine poses lower ranking billionaires like Bill Gates and Warren Buffett as the richest men in the World. Retired management consultant Gaylon Ross Sr, author of Who's Who of the Global Elite, has been tipped from a private source that the combined wealth of the Rockefeller family in 1998 was approx (US) $11 trillion and the Rothschilds (U.S.) $100 trillion. However something of an insider's knowledge of the hidden wealth of the elite is contained in the article, "Will the Dollar and America Fall Down on August 19?.." on page 1 of the 12th July 2001 issue of Russian newspaper Pravda. The newspaper interviewed Tatyana Koryagina, a senior research fellow in the Institute of Macroeconomic Researches subordinated to the Russian Ministry of Economic Development (Minekonom) on the subject of a recent conference concerning the fate of the U.S. economy:
Koryagina:

The known history of civilization is merely the visible part of the iceberg. There is a shadow economy, shadow politics and also a shadow history, known to conspirologists. There are [unseen] forces acting in the World, unstoppable for [most powerful] countries and even continents.

Invader Zim wrote:Whata pile of banal paraniod crap.

You actually read it?